
Hong Kong· Hong KongClearmind Medicine expands PTSD patent portfolio with Hong Kong patent application
Clearmind Medicine has expanded its patent portfolio for PTSD treatment by filing a patent application in Hong Kong.
Background
Hong Kong operates under a 'One Country, Two Systems' framework, granting it a high degree of autonomy except in defense and foreign affairs. This unique status influences its legal and economic environment, making it a significant hub for international business and intellectual property filings.
Quorum · collective opinions
Clearmind Medicine expands PTSD patent portfolio with Hong Kong patent application
First report 12h agoLast update 12h agoThe company is strengthening its intellectual property for PTSD treatments through new patent applications.
iWitness comments
No comments yet — be the first to weigh in.